scispace - formally typeset
B

B. Brett Finlay

Researcher at University of British Columbia

Publications -  609
Citations -  69318

B. Brett Finlay is an academic researcher from University of British Columbia. The author has contributed to research in topics: Virulence & Effector. The author has an hindex of 135, co-authored 588 publications receiving 61894 citations. Previous affiliations of B. Brett Finlay include Vaccine and Infectious Disease Organization & Canadian Institute for Advanced Research.

Papers
More filters
Journal ArticleDOI

Cryo-EM structure of the EspA filament from enteropathogenic Escherichia coli: Revealing the mechanism of effector translocation in the T3SS.

TL;DR: In this article, the authors describe the structure of the EspA filament from the enteropathogenic Escherichia coli (EPEC) at 3.6-A resolution, showing positively charged residues adjacent to a hydrophobic groove line the lumen of the filament in a spiral manner.
Journal ArticleDOI

Differences in the fecal microbiota of dairy calves reared with differing sources of milk and levels of maternal contact

TL;DR: Preliminary evidence of the effects of early rearing environments on the establishment of the dairy calf fecal microbiota is provided, given the critical role of the bovine gut microbiome in behavioral, metabolic, and immune development.
Journal ArticleDOI

Early-life cytomegalovirus infection is associated with gut microbiota perturbations and increased risk of atopy.

TL;DR: Early-life CMV infection is associated with an alteration in the intestinal microbiota, which mediates the effect of the infection on childhood atopy, and a CMV vaccine, in addition to preventing CMV-associated morbidity and mortality, might reduce the risk of childhood allergic diseases.
Journal ArticleDOI

Structural and Cellular Insights into the l,d-Transpeptidase YcbB as a Therapeutic Target in Citrobacter rodentium, Salmonella Typhimurium, and Salmonella Typhi Infections.

TL;DR: Cumulatively, this work provides a foundation for the development of novel YcbB-specific antibacterial therapeutics to assist in treatment of increasingly drug-resistant S. Typhi infections.
Journal ArticleDOI

Dietary Intervention Reverses Fatty Liver and Altered Gut Microbiota during Early-Life Undernutrition.

TL;DR: Exposure to specific gut microbes impacts fatty liver pathology in mice fed a protein/fat-deficient diet, indicating a crucial window in early-life development that, when disrupted by nutritional deficiency, may significantly influence liver function.